Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC19A3 |
Upstream (Parents) |
---|
(<<) QPRT → SLC19A3 |
(<<) ABAT → SLC19A3 |
(<<) CYP2B7P1///CYP2B6 → SLC19A3 |
(<<) PBLD → SLC19A3 |
(<<) PTP4A1 → SLC19A3 |
Downstream (Children) |
---|
SLC19A3 → CALB1 (>>) |
SLC19A3 → TAF6L (>>) |
SLC19A3 → HES2 (>>) |
SLC19A3 → ROM1 (>>) |
SLC19A3 → TAGLN3 (>>) |
SLC19A3 → C11orf41 (>>) |